Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) - Forecast to 2022
[168 Pages Report] The drug discovery services market is expected to value at USD 7.45 Billion in 2016 and projected to grow at a CAGR of 11.6% to reach USD 14.40 Billion by 2022.
Years considered in this report:
- 2016 Base Year
- 2017 Estimated Year
- 2022 Projected Year
The objectives of this study are as follows:
- To define, describe, segment, and forecast the market on the basis of process, type, drug type, therapeutic area, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restrains, opportunities, and burning issues)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders
- To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
- To profile key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies
- To track and analyze competitive developments such as agreements, partnerships, acquisitions, in the market
Research Methodology
Top-down and bottom-up approaches were used to estimate and validate the size of the global drug discovery services market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by process, type, drug type, therapeutic area, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources referred to for this research study include publications from government sources such as white papers; articles from recognized authors; gold standard and silver standard websites, directories, and databases; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations have been used to identify and collect information useful for this extensive commercial study of the global market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the drug discovery services market. The breakdown of profiles of primaries is shown in the figure below:
To know about the assumptions considered for the study, download the pdf brochure
Key players operating in the drug discovery services market include Thermo Fisher Scientific (US), Albany Molecular Research Inc. (AMRI) (US), Charles River Laboratories International (US), Evotec (Germany), Domainex (UK), GenScript (US), Covance (US), Selcia Limited (UK), Viva Biotech (China), WuXi AppTec (China), SRI International (US), Pharmaceutical Product Development, LLC (PPD) (US), GVK Biosciences (India), Jubilant Biosys (India), GE Healthcare (US), Merck (Germany), Lonza (Switzerland), Piramal Enterprises (India), Advinus Therapeutics (India), Promega Corporation (US), Syngene International Ltd. (India), Aurigene (India), Agilent Technologies (US), Ubiquigent (UK), and ChemBridge Corporation (US).
Target Audience for this Report:
- Research Institutes
- Pharmaceutical and Biotechnological Companies
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Value Addition for the Buyer:
This report aims to provide insights into the global drug discovery services market. It provides valuable information on drug discovery services and their process, types, drug types, and therapeutic areas. Details on regional markets for these segments have also been presented in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market.
Scope of the Report:
This report categorizes the drug discovery services market into the following segments:
By Process
- Target Selection
- Target Validation
- Hit-to-lead Identification
- Lead Optimization
- Candidate Validation
By Type
- Medicinal Chemistry
- Biology Services
- Drug Metabolism and Pharmacokinetics (DMPK)
By Drug Type
- Small Molecules
- Biologics
By Therapeutic Area
- Oncology
- Neurology
- Cardiovascular Diseases
- Respiratory Diseases
- Diabetes
- Other Therapeutic Areas
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Rest of Europe (RoE)
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific (RoAPAC)
- Rest of the World (RoW)
Customization Options:
- Company Information: Detailed company profiles of five or more market players
- Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market
Drug discovery services are widely used in forensics, paternity testing, disaster victim identification, and anthropology with DNA analysis/profiling being a key tool in this sector. The global drug discovery services market is expected to reach USD 14.40 Billion by 2022 from USD 8.32 Billion in 2017, at a CAGR of 11.6%. The major factors driving the growth of this market are increasing research and development expenditure, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles, and increasing demand for outsourcing of analytical testing and clinical trial services.
The drug discovery services market is segmented on the basis of process, type, drug type, and therapeutic area. On the basis of process, the global market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. The hit-to-lead identification segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to emerging advanced technologies for high-throughput screening (HTS).
Based on type, the drug discovery services market is segmented into medicinal chemistry, biology services, and drug metabolism and pharmacokinetics (DMPK). In 2017, the medicinal chemistry segment is expected to account for the largest share of the market. Increasing R&D expenditure, growing number of drug discovery and developmental activities, and increasing inclination of pharmaceutical companies towards outsourcing are among the major factors driving the growth of the medicinal chemistry segment.
On the basis of drug type, the drug discovery services market is segmented into small molecules and biologics. In 2017, the small molecules segment is expected to account for the largest share of the global market. Small molecule drugs are simple, well defined, and easy to characterize. Due to their features, they can easily enter cells, affect other molecules, and cause cancer cells to die. As a result, many targeted therapies are small molecules or small-molecule inhibitors.
By therapeutic area, the drug discovery services market is segmented into oncology, neurology, cardiovascular diseases, respiratory diseases, diabetes, and other therapeutic areas. In 2017, the oncology segment is expected to account for the largest share of the global market. The market is mainly driven by increasing number of cancer patients, which leads to a high demand for cancer therapies.
By region, the drug discovery services market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe. However, the Asia Pacific region is expected to witness the highest growth during the forecast period due to less stringent regulations and economical manufacturing costs.
The high cost involved in drug discovery & development and stringent regulations governing drug discovery and animal usage are expected to restrain market growth during the forecast period.
Albany Molecular Research Inc. (AMRI) (US), Charles River Laboratories (US), Evotec (Germany), Domainex (UK), GenScript (US), Covance (US), WuXi AppTec (China), Pharmaceutical Product Development, LLC (PPD) (US), Jubilant Biosys (India), GE Healthcare (US), Merck (Germany), Piramal Enterprises (India), and Advinus Therapeutics (India) are some of the leading players in this market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 19)
2.1 Research Data
2.2 Secondary Data
2.2.1 Key Data From Secondary Sources
2.3 Primary Data
2.3.1 Key Data From Primary Sources
2.4 Market Size Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Data Triangulation
2.6 Assumptions for the Study
3 Executive Summary (Page No. - 27)
4 Premium Insights (Page No. - 32)
4.1 Drug Discovery Services Market Overview
4.2 European Market Share, By Therapeutic Area and Country
4.3 Global Market, By Type
4.4 Geographical Snapshot of the Global Market
5 Market Overview (Page No. - 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing R&D Expenditure
5.2.1.2 Increasing Demand for Outsourcing Analytical Testing and Clinical Trial Services
5.2.1.3 Initiatives for Research on Rare Diseases
5.2.1.4 Focus on Drug Discovery
5.2.2 Restraints
5.2.2.1 High Cost of Drug Discovery and Development
5.2.2.2 Stringent Regulations Governing Drug Discovery, and Animal Usage
5.2.3 Opportunities
5.2.3.1 Introduction of Advanced Technologies
5.2.3.2 Patent Expiries to Boost the Demand for Drug Discovery
5.2.4 Burning Issues
5.2.4.1 Need for Harmonization of Regulations, Ip Rights
6 Drug Discovery Services Market, By Process (Page No. - 44)
6.1 Introduction
6.2 Target Selection
6.3 Target Validation
6.4 Hit-To-Lead Identification
6.5 Lead Optimization
6.6 Candidate Validation
7 Drug Discovery Services Market, By Type (Page No. - 51)
7.1 Introduction
7.2 Medicinal Chemistry
7.3 Biology Services
7.4 Drug Metabolism and Pharmacokinetics (DMPK)
8 Drug Discovery Services Market, By Drug Type (Page No. - 56)
8.1 Introduction
8.2 Small Molecules
8.3 Biologics
9 Drug Discovery Services Market, By Therapeutic Area (Page No. - 60)
9.1 Introduction
9.2 Oncology
9.3 Neurology
9.4 Cardiovascular Diseases
9.5 Respiratory Diseases
9.6 Diabetes
9.7 Other Therapeutic Areas
10 Drug Discovery Services Market, By Region (Page No. - 69)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Rest of Europe (RoE)
10.4 Asia Pacific (APAC)
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific (RoAPAC)
10.5 Rest of the World (RoW)
11 Competitive Landscape (Page No. - 115)
11.1 Market Share Analysis
12 Company Profiles (Page No. - 116)
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
12.1 Thermo Fisher Scientific
12.2 Merck
12.3 GE Healthcare
12.4 Albany Molecular Research, Inc. (AMRI)
12.5 Charles River Laboratories International
12.6 Evotec
12.7 Pharmaceutical Product Development, LLC. (Ppd)
12.8 Jubilant Biosys
12.9 Covance
12.10 Genscript Biotech Corporation
12.11 Aurigene Discovery Technologies
12.12 Wuxi Apptec
12.13 Syngene
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. - 159)
13.1 Industry Insights
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details
List of Tables (92 Tables)
Table 1 Total Global Pharmaceutical R&D Spending, 2012 to 2022 (USD Billion)
Table 2 R&D Spending, Phrma Member-Companies (USD Billion)
Table 3 Activities Outsourced in the Pharmaceutical Industry (2014 vs 2015)
Table 4 Research Projects Funded By Irdirc Bodies
Table 5 Average Cost of Drugs Approved By Year
Table 6 Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 7 Target Selection Market, By Region, 20152022 (USD Million)
Table 8 Target Validation Market, By Region, 20152022 (USD Million)
Table 9 Hit-To-Lead Identification Process Market, By Region, 20152022 (USD Million)
Table 10 Lead Optimization Market, By Region, 20152022 (USD Million)
Table 11 Candidate Validation Market, By Region, 20152022 (USD Million)
Table 12 Drug Discovery Services Market, By Type, 20152022 (USD Million)
Table 13 Medicinal Chemistry Services Market, By Region, 20152022 (USD Million)
Table 14 Biology Services Market, By Region, 20152022 (USD Million)
Table 15 Drug Metabolism and Pharmacokinetics Services Market, By Region, 20152022 (USD Million)
Table 16 Drug Discovery Services Market, By Drug Type, 20152022 (USD Million)
Table 17 Small Molecules Market, By Region, 20152022 (USD Million)
Table 18 Biologics Market, By Region, 20152022 (USD Million)
Table 19 Global Number of Clinical Trials in Different Therapeutic Areas, 2016
Table 20 Global Drug Discovery Services Market, By Therapeutic Area, 20152022 (USD Million)
Table 21 Market for Oncology, By Region, 20152022 (USD Million)
Table 22 Market for Neurology, By Region, 20152022 (USD Million)
Table 23 Market for Cardiovascular Diseases, By Region, 20152022 (USD Million)
Table 24 Market for Respiratory Diseases, By Region, 20152022 (USD Million)
Table 25 Drug Discovery Services Market for Diabetes, By Region, 20152022 (USD Million)
Table 26 Market for Other Therapeutic Areas, By Region, 20152022 (USD Million)
Table 27 Market, By Region, 20152022 (USD Million)
Table 28 North America: Drug Discovery Services Market, By Country, 20152022 (USD Million)
Table 29 North America: Market, By Process, 20152022 (USD Million)
Table 30 North America: Market, By Type, 20152022 (USD Million)
Table 31 North America: Market, By Drug Type, 20152022 (USD Million)
Table 32 North America: Market, By Therapeutic Area, 20152022 (USD Million)
Table 33 US: Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 34 US: Market, By Type, 20152022 (USD Million)
Table 35 US: Market, By Drug Type, 20152022 (USD Million)
Table 36 US: Market, By Therapeutic Area, 20152022 (USD Million)
Table 37 Canada: Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 38 Canada: Market, By Type, 20152022 (USD Million)
Table 39 Canada: Market, By Drug Type, 20152022 (USD Million)
Table 40 Canada: Market, By Therapeutic Area, 20152022 (USD Million)
Table 41 Europe: Pharmaceutical R&D Expenditure, By Country, 2012 & 2014
Table 42 Europe: Market, By Country/Region, 2015 2022 (USD Million)
Table 43 Europe: Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 44 Europe: Market, By Type, 20152022 (USD Million)
Table 45 Europe: Market, By Drug Type, 20152022 (USD Million)
Table 46 Europe: Market, By Therapeutic Area, 20152022 (USD Million)
Table 47 Pharmaceutical R&D Investments in Germany (20102014)
Table 48 Germany: Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 49 Germany: Market, By Type, 20152022 (USD Million)
Table 50 Germany: Market, By Drug Type, 20152022 (USD Million)
Table 51 Germany: Market, By Therapeutic Area, 20152022 (USD Million)
Table 52 UK: Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 53 UK: Market, By Type, 20152022 (USD Million)
Table 54 UK: Market, By Drug Type, 20152022 (USD Million)
Table 55 UK: Market, By Therapeutic Area, 20152022 (USD Million)
Table 56 France: Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 57 France: Market, By Type, 20152022 (USD Million)
Table 58 France: Market, By Drug Type, 20152022 (USD Million)
Table 59 France: Market, By Therapeutic Area, 20152022 (USD Million)
Table 60 Pharmaceutical R&D Investments in Italy, 20092014
Table 61 Pharmaceutical R&D Expenditure in Belgium, 20102014
Table 62 Pharmaceutical Production and R&D Expenditure in Denmark, 20122014
Table 63 RoE: Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 64 RoE: Market, By Type, 20152022 (USD Million)
Table 65 RoE: Market, By Drug Type, 20152022 (USD Million)
Table 66 RoE: Market, By Therapeutic Area, 20152022 (USD Million)
Table 67 Total Number of Clinical Trials in APAC, By Therapeutic Area, 2016
Table 68 APAC: Drug Discovery Services Market, By Country/Region, 20152022 (USD Million)
Table 69 APAC: Market, By Process, 20152022 (USD Million)
Table 70 APAC: Market, By Type, 20152022 (USD Million)
Table 71 APAC: Market, By Drug Type, 20152022 (USD Million)
Table 72 APAC: Market, By Therapeutic Area, 20152022 (USD Million)
Table 73 China: Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 74 China: Market, By Type, 20152022 (USD Million)
Table 75 China: Market, By Drug Type, 20152022 (USD Million)
Table 76 China: Market, By Therapeutic Area, 20152022 (USD Million)
Table 77 Japan: Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 78 Japan: Market, By Type, 20152022 (USD Million)
Table 79 Japan: Market, By Drug Type, 20152022 (USD Million)
Table 80 Japan: Market, By Therapeutic Area, 20152022 (USD Million)
Table 81 India: Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 82 India: Market, By Type, 20152022 (USD Million)
Table 83 India: Market, By Drug Type, 20152022 (USD Million)
Table 84 India: Market, By Therapeutic Area, 20152022 (USD Million)
Table 85 RoAPAC: Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 86 RoAPAC: Market, By Type, 20152022 (USD Million)
Table 87 RoAPAC: Market, By Drug Type, 20152022 (USD Million)
Table 88 RoAPAC: Market, By Therapeutic Area, 20152022 (USD Million)
Table 89 RoW: Drug Discovery Services Market, By Process, 20152022 (USD Million)
Table 90 RoW: Market, By Type, 20152022 (USD Million)
Table 91 RoW: Market, By Drug Type, 20152022 (USD Million)
Table 92 RoW: Market, By Therapeutic Area, 20152022 (USD Million)
List of Figures (39 Figures)
Figure 1 Global Drug Discovery Services Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Data Triangulation Methodology
Figure 5 Drug Discovery Services Market, By Process, 2017 vs 2022 (USD Billion)
Figure 6 Global Market, By Type, 2017 vs 2022 (USD Billion)
Figure 7 Global Market, By Drug Type, 2017 vs 2022 (USD Billion)
Figure 8 Global Market, By Therapeutic Area, 2017 vs 2022 (USD Billion)
Figure 9 Global Market, By Region, 2017 vs 2022 (USD Billion)
Figure 10 Increasing Demand for Outsourcing of Analytical Testing and Clinical Trial Services to Drive Market Growth
Figure 11 Oncology Segment to Command the Largest Market Share of European Drug Discovery Services Market in 2017
Figure 12 Medicinal Chemistry to Register the Highest CAGR During the Forecast Period (2017-2022)
Figure 13 Asia Pacific to Register the Highest CAGR Between 2017 & 2022
Figure 14 Drug Discovery Services Market: Drivers, Restraints, and Opportunities
Figure 15 Number of Registered Studies (2000-2017)
Figure 16 Hit-To-Lead Identification to Hold Largest Market Share in 2017
Figure 17 Medicinal Chemistry Segment to Account for the Largest Share of the Drug Discovery Services Market
Figure 18 Small MoleculesThe Largest Segment in the Global Market, By Drug Types
Figure 19 Oncology Segment to Hold the Largest Share in Global Market in 2017
Figure 20 Total Number of Clinical Trials for Oncology (2016)
Figure 21 Geographic Snapshot (2016): APAC Markets are Emerging as New Growth Hotspots
Figure 22 North America: Drug Discovery Services Market Snapshot
Figure 23 Pharmaceutical R&D Expenditure in the US (1990-2014)
Figure 24 Total Canadian Pharmaceutical Trade (20042016) (USD Billion)
Figure 25 Yearly Employment in Manufacturing Portion of Pharmaceutical Sector (20052016)
Figure 26 Pharmaceutical R&D Expenditure in Europe (20102014)
Figure 27 Europe: Market Snapshot
Figure 28 APAC: Market Snapshot
Figure 29 Global Market: Market Share (2016)
Figure 30 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 31 Merck: Company Snapshot (2016)
Figure 32 GE Healthcare: Company Snapshot (2016)
Figure 33 Albany Molecular Research, Inc.: Company Snapshot (2016)
Figure 34 Charles River Laboratories International: Company Snapshot (2016)
Figure 35 Evotec: Company Snapshot (2016)
Figure 36 Jubilant Biosys: Company Snapshot (2016)
Figure 37 Labcorp: Company Snapshot (2016)
Figure 38 Genscript Biotech Corporation: Company Snapshot (2016)
Figure 39 Syngene: Company Snapshot (2016)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Drug Discovery Services Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Drug Discovery Services Market